Article
Allosteric communication between ACE2 active site and binding interface with SARS-CoV-2.
The Journal of chemical physics - 7 Jun 2023
Mugnai Mauro L, Thirumalai D
Abstract excerpt
SARS-CoV-2, the virus causing COVID-19, initiates cell invasion by deploying a receptor binding domain (RBD) to recognize the host transmembrane peptidase angiotensin-converting enzyme 2 (ACE2). Numerous experimental and theoretical studies have adopted high-throughput and structure-guided approaches to (i) understand how the RBD recognizes ACE2, (ii) rationalize, and (iii) predict the effect of viral mutations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
